OTC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of OTC Antibodies for studying ornithine transcarbamylase (OTC). OTC Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ornithine transcarbamylase plays a crucial role in the urea cycle, facilitating the conversion of ornithine and carbamoyl phosphate into citrulline. This process is essential for the detoxification of ammonia in the liver, making ornithine transcarbamylase vital for metabolic health. Deficiencies in ornithine transcarbamylase can lead to severe metabolic disorders, highlighting the significance of ongoing research in both clinical and research settings. Understanding ornithine transcarbamylase function and regulation provides valuable insights into metabolic disease mechanisms and potential therapeutic approaches. Research using ornithine transcarbamylase has revealed important connections between urea cycle disorders and various metabolic conditions. Investigating ornithine transcarbamylase expression patterns helps identify biomarkers for early disease detection and monitoring. Santa Cruz Biotechnology monoclonal antibodies for ornithine transcarbamylase support researchers worldwide in advancing metabolic disease research and therapeutic development.